Breast Cancer Clinical Trials

Find Breast Cancer Clinical Trials Near You

Comparison of Postoperative Analgesic Efficacy of Superior Posterior Serratus Intercostal Plane Block (SPSIP) and Anterior Serratus Plane Block in Modified Radical Mastectomy Surgery

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Postoperative pain following modified radical mastectomy remains a significant clinical challenge and may delay recovery, impair patient comfort, and increase opioid consumption. Ultrasound-guided fascial plane blocks have become an important component of multimodal analgesia for breast surgery. The serratus anterior plane block (SAPB) is an established regional anesthesia technique that provides effective postoperative analgesia. The serratus posterior superior intercostal plane block (SPSIPB) is a recently described interfascial block with promising analgesic effects, but evidence comparing its efficacy with SAPB in breast surgery remains limited. This prospective, randomized, double-blind, single-center clinical trial aims to compare the postoperative analgesic efficacy of ultrasound-guided SPSIPB and SAPB in patients undergoing modified radical mastectomy under general anesthesia. Seventy female patients aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I-III will be randomly assigned to receive either SPSIPB or SAPB before surgery. The primary outcome is postoperative pain intensity assessed using the Visual Analog Scale (VAS). Secondary outcomes include intraoperative remifentanil consumption, cumulative tramadol consumption during the first 24 postoperative hours, postoperative nausea and vomiting (PONV), quality of recovery assessed with the QoR-40 questionnaire, rescue analgesic requirements, and block-related complications. The findings of this study are expected to provide evidence regarding the comparative effectiveness and safety of these two interfascial plane blocks for postoperative analgesia in breast cancer surgery.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Female patients aged 18 to 65 years.

• Scheduled for elective modified radical mastectomy under general anesthesia.

• American Society of Anesthesiologists (ASA) physical status I-III.

• Body mass index (BMI) \<35 kg/m².

• Normal coagulation profile (including INR and platelet count).

• Normal liver and renal function tests.

• Able to understand the study procedures and provide written informed consent.

Locations
Other Locations
Turkey
Sultan 2. Abdulhamid Han Training and Research Hospital
RECRUITING
Istanbul
Contact Information
Primary
Dilek M Yamac, MD
ddilekmetin@hotmail.com
+905054959792
Backup
Dilek M Yamac
ddilekmetin@hotmail.com
05054959792
Time Frame
Start Date: 2026-08-01
Estimated Completion Date: 2027-03-01
Participants
Target number of participants: 70
Treatments
Experimental: SPSIP Block
Participants will receive an ultrasound-guided Serratus Posterior Superior Intercostal Plane Block (SPSIPB) using 30 mL of 0.25% bupivacaine before induction of general anesthesia. General anesthesia and postoperative analgesic management will be standardized for all participants.
Active_comparator: SAP Block
Participants will receive an ultrasound-guided Serratus Anterior Plane Block (SAPB) using 30 mL of 0.25% bupivacaine before induction of general anesthesia. General anesthesia and postoperative analgesic management will be standardized for all participants.
Related Therapeutic Areas
Sponsors
Leads: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

This content was sourced from clinicaltrials.gov

Similar Clinical Trials